Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2017 May;21(2):513-519.
doi: 10.1007/s11325-017-1478-5. Epub 2017 Feb 11.

Intelligent volume-assured pressured support (iVAPS) for the treatment of congenital central hypoventilation syndrome

Affiliations
Clinical Trial

Intelligent volume-assured pressured support (iVAPS) for the treatment of congenital central hypoventilation syndrome

Abdullah Khayat et al. Sleep Breath. 2017 May.

Abstract

Purpose: Congenital central hypoventilation syndrome (CCHS) is characterized by ventilatory insensitivity to hypercapnia and hypoxemia during sleep and/or wakefulness. Management of CCHS includes a long-term ventilation. However, ventilation can be challenging given differences in the control of breathing during different sleep stages. Intelligent volume-assured pressure support (iVAPS) is a mode of Bi-level positive airway pressure (BPAP) ventilation in which the pressure support is modulated to ensure a constant alveolar ventilation. The aim of this study was to determine if BPAP with iVAPS mode is more effective at controlling hypercapnia than BPAP with spontaneous/timed (S/T) mode.

Methods: A retrospective chart review of CCHS patients who underwent both a titration polysomnogram (PSG) with standard BPAP S/T mode and a consecutive follow-up study with BPAP iVAPS mode at The Hospital for Sick Children, Toronto, Canada, between January 1, 2013 and September 30, 2015 were included. Comparisons were made between S/T mode and iVAPS mode.

Results: Eight (four males) children with CCHS were included. The median (IQR) age at the time of PSG using Bi-level ventilation with S/T mode for study participants was 10.0 (IQR 8.4, 11.6) years followed by PSGs with iVAPS mode, median age 10.6 (IQR 9.1, 12.5) years. The non-rapid eye movement (NREM) peak transcutaneous CO2 (tcCO2) median (IQR) for iVAPS was 43.0 (40.0-46.0-) mmHg versus 46.5 (45.0-48.0) mmHg for S/T mode, (p value <0.05).

Conclusion: iVAPS was associated with a reduction in the maximum tcCO2 during NREM sleep as compared to traditional S/T mode. Prospective, longitudinal studies are needed to evaluate the benefits of BPAP therapy iVAPS mode for the treatment of pediatric CCHS.

Keywords: Central sleep apnea; Congenital central hypoventilation syndrome; Intelligent volume-assured pressure support; Pediatrics; Sleep disordered breathing.

PubMed Disclaimer

References

    1. Am J Respir Crit Care Med. 2005 Jan 1;171(1):88 - PubMed
    1. J Appl Physiol (1985). 2014 Feb 15;116(4):439-50 - PubMed
    1. Can Respir J. 2011 Mar-Apr;18(2):87-9 - PubMed
    1. Thorax. 2012 Aug;67(8):727-34 - PubMed
    1. Respirology. 2014 May;19(4):596-603 - PubMed

Publication types

Supplementary concepts

LinkOut - more resources